Cardiovascular Biomarkers and Their Utility in the Older Adult

被引：2

作者：

Bell S.P. ^{[1
]}

Giuseffi J.L. ^{[1
]}

Forman D.E. ^{[2
,3
]}

机构：

[1] Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232-6300, 383 PRB

[2] Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA

[3] New England GRECC (Geriatric Research, Education, and Clinical Center), Boston VA Healthcare System, Boston, MA

来源：

Current Cardiovascular Risk Reports | 2012年 / 6卷 / 5期

关键词：

Aging; Biomarkers; C-reactive protein; Cardiovascular disease; Cardiovascular risk; Elderly; Heart failure; Inflammation;

D O I：

10.1007/s12170-012-0262-0

中图分类号：

学科分类号：

摘要：

Cardiovascular disease is the leading cause of morbidity and mortality in individuals over the age of 65, yet diagnosis, risk stratification and management continue to be more challenging than in younger adults due to the vast heterogeneity seen in this population. The current literature validates the use of biomarkers in addition to traditional risk assessment tools in younger and middle-aged adults. The evidence for biomarkers in this older population is sparse; this review examines the epidemiological association of current biomarkers in the field and the utility of these markers in the diagnosis, risk discrimination, and management of cardiovascular disease. © 2012 Springer Science+Business Media, LLC.

引用

页码：397 / 403

页数：6

共 50 条

[1]

Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B., Prediction of coronary heart disease using risk factor categories, Circulation, 97, 18, pp. 1837-1847, (1998)

[2]

Pearson T.A., Mensah G.A., Alexander R.W., Et al., Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association, Circulation, 107, 3, pp. 499-511, (2003)

[3]

Willerson J.T., Ridker P.M., Inflammation as a cardiovascular risk factor, Circulation, 109, 21 SUPPL. 1, pp. 2-10, (2004)

[4]

Libby P., Inflammation in atherosclerosis, Nature, 420, 6917, pp. 868-874, (2002)

[5]

Ross R., Atherosclerosis-an inflammatory disease, N Engl J Med, 340, 2, pp. 115-126, (1999)

[6]

Pai J.K., Pischon T., Ma J., Et al., Inflammatory markers and the risk of coronary heart disease in men and women, N Engl J Med, 351, 25, pp. 2599-2610, (2004)

[7]

Ridker P.M., Buring J.E., Shih J., Matias M., Hennekens C.H., Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women, Circulation, 98, 8, pp. 731-733, (1998)

[8]

Tracy R.P., Lemaitre R.N., Psaty B.M., Et al., Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project, Arterioscler Thromb Vasc Biol, 17, 6, pp. 1121-1127, (1997)

[9]

Tice J.A., Browner W., Tracy R.P., Cummings S.R., The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women, Am J Med, 114, 3, pp. 199-205, (2003)

[10]

Cesari M., Penninx B.W., Newman A.B., Et al., Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study), Am J Cardiol, 92, 5, pp. 522-528, (2003)

← 1 2 3 4 5 →